Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant Human Porphobilinogen Deaminase

EU orphan designation number: EU/3/02/103   
Active ingredient: Recombinant Human Porphobilinogen Deaminase
Indication: Treatment of acute intermittent porphyria
Sponsor: Zymenex A/S
Roskildevej 12C, DK-3400 Hillerød, Danmark

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
14/06/2002 Centralised Orphan - Designation EMEA/OD/083/01 (2002)2231 of 12/06/2002
04/02/2005 Other procedure